Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
about
Implicit Memory in Monkeys: Development of a Delay Eyeblink Conditioning System with Parallel Electromyographic and High-Speed Video MeasurementsOpposing effects of ketamine and acetyl L-carnitine on the serotonergic system of zebrafish.Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine.Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors.Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-d-aspartate and opioid receptors.The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders.Schizophrenia and depression, two poles of endocannabinoid system deregulation.S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT1B Receptor Dependent Mechanism in a Genetic Rat Model of Depression.Role of 5-HT1A receptor stimulation in the medial prefrontal cortex in the sustained antidepressant effects of ketamine.Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain.
P2860
Q27304571-CE6C5646-53FC-4E5C-9DD0-A8E075BD4B79Q37114029-86C63722-5E8E-4A48-A653-B3C684F8D1B5Q37662689-5D35D0C2-0E10-4C1B-A492-265DB82925F2Q39005986-02093BE0-16D4-4DA4-832A-3A6210127253Q39427905-6494F1C8-1D4C-41C0-A954-EE3C1C92E7B5Q41037541-FCF70BC6-2F4A-4513-8B3D-F27E8088850FQ44336103-B4B11BAE-275A-4B08-9975-4C5D7D5FE8B6Q46296210-3EFC92F7-E9EA-43C5-9F18-322E1E6AE487Q47284001-4F9C3BF8-1A41-4939-BD49-00CF81B981CDQ47643467-B840AF43-381A-4753-B4A1-82A7863E7DF7Q47662037-26B10663-3577-4780-8EEF-C9CA20D01750Q50089992-5C6C9DFF-EE57-43B5-B470-46F170783DCCQ55438088-69017778-214F-49ED-AF1C-1EEECD1EB722Q55711478-D4F463FD-08AB-43B2-90B3-FD2234E4E415
P2860
Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@en
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@nl
type
label
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@en
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@nl
prefLabel
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@en
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@nl
P2093
P2860
P356
P1476
Subanesthetic doses of ketamin ...... ET study in conscious monkeys.
@en
P2093
Edward F Domino
Hideo Tsukada
Hiroyuki Ohba
Norihiro Harada
Shigeyuki Yamamoto
Shingo Nishiyama
Takeharu Kakiuchi
P2860
P2888
P304
P356
10.1038/NPP.2013.176
P407
P577
2013-07-24T00:00:00Z
P6179
1049962382